Background-Imaging of myocardial ablation lesions during electrophysiology procedures would enable superior guidance of interventions and immediate identification of potential complications. The aim of this study was to establish clinically suitable MRI-based imaging techniques for intraprocedural lesion visualization in interventional electrophysiology. Methods and Results-Interventional electrophysiology was performed under magnetic resonance guidance in an animal model, using a custom setup including magnetic resonance-conditional catheters. Various pulse sequences were explored for intraprocedural lesion visualization after radiofrequency ablation. The developed visualization techniques were then used to investigate lesion formation in patients immediately after ablation of atrial flutter. The animal studies in 9 minipigs showed that gadolinium-DTPA-enhanced T1-weighted and nonenhanced T2-weighted pulse sequences are particularly suitable for lesion visualization immediately after radiofrequency ablation. MRI-derived lesion size correlated well with autopsy (R 2 ϭ0.799/0.709 for contrast-enhanced/nonenhanced imaging). Non-contrast agentenhanced techniques were suitable for repetitive lesion visualization during electrophysiological interventions, thus allowing for intraprocedural monitoring of ablation success. The patient studies in 24 patients with typical atrial flutter several minutes to hours after cavotricuspid isthmus ablation confirmed the results from the animal experiments. Therapeutic lesions could be visualized in all patients using contrast-enhanced and also nonenhanced MRI with high contrast-to-noise ratio (94.6Ϯ35.2/111.1Ϯ32.6 versus 48.0Ϯ29.0/68.0Ϯ37.3 for ventricular/atrial lesions and contrastenhanced versus nonenhanced imaging). Conclusions-MRI allows for precise lesion visualization in electrophysiological interventions just minutes after radiofrequency ablation. Nonenhanced T2-weighted MRI is particularly feasible for intraprocedural delineation of lesion formation as lesions are detectable within minutes after radiofrequency delivery and imaging can be repeated during interventions. (Circ Cardiovasc Imaging. 2011;4:282-294.)
T oday, electrophysiological examinations and interventions are usually performed under fluoroscopic guidance. Among the main weaknesses of this imaging technique is the inability to generate sufficient soft tissue contrast. Therefore, these procedures are increasingly complemented by additional imaging modalities, allowing for the acquisition of additional 3-dimensional anatomic information, such as preprocedural MRI and electroanatomic mapping. However, even with the use of such complex and time-consuming additional techniques, the inability to directly visualize therapeutic effects remains, which is one of the main weaknesses in present interventional electrophysiology. Intraprocedural MRI has been proposed as an alternative imaging modality for guiding and monitoring electrophysiological investigations. Magnetic resonance technology provides superior 3-D anatomic and functional information and avoids ionizing radiation or iodine contrast agents. Compared with fluoroscopic imaging, MRI potentially offers a broad spectrum of additional data. Allowing 3-D data acquisition, MRI enables exact anatomic visualization and precise catheter guidance to specific target regions, which potentially increases patient safety. Providing unsurpassed soft tissue contrast, MRI may also help identifying the arrhythmogenic substrate or even directly visualize therapeutic lesions after interventional electrophysiological procedures, as demonstrated before. [1] [2] [3] [4] [5] [6] [7] [8] Intraprocedural accurate feedback of lesion formation during therapy could reduce procedural time and patient risk and increase efficacy of electrophysiological interventions. These potential advantages position magnetic resonance-guided electrophysiology uniquely for complex interventions in the near future. 9
Clinical Perspective on p 294
Therefore, the field has been actively working on overcoming the various technical challenges to use MRI for real-time guidance of electrophysiological interventions. First studies reported on feasibility of real-time MRI for catheter guidance in diagnostic electrophysiology studies 10 and electroanatomic mapping with magnetic resonance-based catheter tracking. 11 Just recently, even complex electrophysiological interventions such as AV modulation 12 and isthmus ablation 13 under magnetic resonance guidance have been performed using a magnetic resonance-conditional electrophysiology setup.
The aim of the current study was to establish intraprocedural visualization of therapeutic electrophysiological lesions in MRI. Various pulse sequences were first tested in a large animal model. The developed imaging techniques were then used to visualize therapeutic lesions in patients with atrial flutter shortly after cavotricuspid isthmus ablation. We anticipate that not only contrast-enhanced but also nonenhanced MRI is suitable for accurate lesion visualization immediately after radiofrequency ablation. Because nonenhanced MRI is fast and easily repeatable, it would have important implications on the applicability during interventions compared with contrast-enhanced MRI.
Methods
The experimental protocol was approved by the local ethics committee and the governmental animal care and use committee (Regierung von Unterfranken, approval No. 54-2531.01-63/04). Written informed consent was obtained from all patients on all procedures.
Experimental Setup for Animal Experiments
To establish an applicable intraprocedural imaging protocol, targeted ablation of selected regions and subsequent lesion imaging was performed in 9 minipigs weighing 40 to 55 kg. A custom electrophysiology platform including a custom steerable nonmetallic ablation catheter (7F, bipolar, with 4-mm tip and 2-mm ring electrode) and custom radiofrequency filters for use in the MRI environment were used for ablation to prevent unintended interactions of the electromagnetic fields inherent in MRI technology with the electrophysiology equipment. The catheter is feasible for passive catheter tracking techniques. A commercially available electrophysiology platform (LabSystem Duo, BARD Electrophysiology, Lowell, MA) and radiofrequency generator were used for electrophysiological investigations and radiofrequency ablation. Electrophysiology setup/ technical equipment for the animal experiments have been described in detail before. 12
Ablation Protocol for Animal Experiments
Before the magnetic resonance experiments, the animals were sedated by intramuscular injection of 10 mg ketamine and set to 1% isoflurane. An intravenous line was established, and an 8F Terumo catheter introducer sheath was inserted in the left jugular vein. With the animal ventilated by an Oxylog ventilator (Draeger Medical, Luebeck, Germany) under general anesthesia (midazolam/fentanyl/ rocuroniumbromide) in the scanner, the catheter was inserted through the sheath from the jugular vein under magnetic resonance guidance using a passive catheter tracking technique. Initially, a stack of catheter tracking images was acquired 90°to the supposed catheter direction. An image showing the catheter longitudinally was then acquired positioning the slice vertically over the catheter, which was repeated with the catheter approaching to the target to keep it in plane. A basic diagnostic electrophysiology routine was performed, including determination of sensing and pacing thresholds in the atrium and ventricle. In each animal, one predefined region, either in the right atrium, right ventricular free wall, septum, or coronary sinus approximately 3 cm behind the ostium, was chosen for ablation to simulate different interventional approaches and include ablation lesions in several ventricular and atrial myocardial tissues. The predefined ablation site was then targeted under magnetic resonance guidance. Once the catheter tip had reached the desired region, focal radiofrequency ablation was performed with maximum power of 75 W/60 s and a temperature cut off at 65°C. Several radiofrequency ablation cycles of 1 minute each were performed. The primary end point of radiofrequency delivery was a significant reduction (Ͼ80%) of the intracardiac electrogram (IEGM) amplitude. Radiofrequency delivery was stopped immediately if bradycardia or tachycardia occurred.
Imaging Protocol for Animal Experiments
MRI was performed at 1.5 T. Pulse excitation used the integrated radiofrequency body coil, and signal was received with a dedicated cardiac surface coil, including a custom-made 32-channel surface coil to improve signal-to-noise ratio (SNR) for visualization of small atrial ablation lesions.
As previously described, fast non-ECG-triggered images-that is, using steady-state free precession (SSFP) (echo time, 1.35 ms; repetition time, 2.69 ms; flip angle, 80°; slice thickness, 4 to 8 mm; matrix, 168ϫ256; total acquisition time, 0.7 seconds) or fast lowangle shot (FLASH) pulse sequences-were repeatedly acquired to guide the catheter to the target region using passive catheter tracking. 12 Lesion visualization began directly after radiofrequency delivery with the catheter still in place, using various experimental and manufacturer-supplied pulse sequences, most importantly, nonenhanced T2-weighted and contrast agent-enhanced T1-weighted (inversion recovery) gradient echo, turbo spin-echo, and FLASH imaging techniques. For contrast agent-enhanced imaging, gadolinium-DTPA was administered at 0.1 mmol/kg body weight, unless stated otherwise. High-resolution images were acquired in end-diastole and end-expiration, using an ECG trigger module and a breath-hold technique. Generally, the imaging protocol started with nonenhanced pulse sequences, subsequently followed by contrast agent-enhanced T1-weighted imaging techniques. Gadolinium-DTPA was injected between 15 minutes and 45 minutes after ablation, and imaging thereafter was performed at different time points after administration of the contrast agent (0 to 120 minutes).
After the electrophysiology and magnetic resonance experiments, the animals were euthanized, and the hearts were excised and sectioned. Location and extend of the radiofrequency lesion were determined at gross examination and compared with the findings on MRI. Lesion size is given as maximum diameter and maximum depth as assessed by MRI. At autopsy, hearts were sliced parallel to magnetic resonance acquisition using landmarks as orientation (eg, right ventricular apex or papillary muscle) to allow direct comparison of lesion size acquired by MRI with the measurement results from pathology.
Clinical Studies
After experimental validation of contrast-enhanced and nonenhanced imaging techniques, we explored the use of sequences successfully tested in animals for intraprocedural visualization of radiofrequency lesions in patients after interventional therapy of atrial flutter. All patients were referred to the magnetic resonance scanner 1 to 3 days before ablation therapy, running a basic imaging protocol to investigate heart morphology and function, including T2-weighted imaging but excluding contrast-enhanced imaging techniques due to contrast agent delivery restrictions. radiofrequency ablation of typical right atrial flutter was then performed using standard techniques and fluoroscopic guidance. A diagnostic 6F electrophysiological catheter was placed in the coronary sinus. In the case of bradycardia, a second diagnostic catheter was placed in the right ventricular outflow tract for backup pacing. Ablation was done with a standard 8-mm-tip ablation catheter (AlCath black, gold tip, Biotronik, Berlin, Germany). Temperature and power maximum were set to 65°C and 75 W, respectively. The end point of ablation was confirmation of bidirectional isthmus blockade by differential pacing on both sites of the ablation line. All patients were monitored several hours after the procedure. Patients were followed up in the outpatient clinic 3 months after ablation.
Lesion Visualization in Patients After Atrial Flutter Ablation
Patients were imaged as soon as clinically feasible at the physician's discretion and Ͻ24 hours after ablation to assess myocardial damage at 1.5 T, using a Gyroscan ACS NT Intera R12 (Philips Medical, Best, The Netherlands) with the integrated body coil for radiofrequency excitation and a 5-channel cardiac array for signal reception, starting with the non enhanced imaging techniques. A T2-weighted ECG-triggered turbo spin-echo sequence with a black blood pulse was used for nonenhanced lesion visualization (echo time, 90 ms; repetition time, Ϸ1850 ms; flip angle, 90°; slice thickness, 4 to 8 mm; field of view, Ϸ340 mm; matrix, 236*195; bandwidth, 481). Delayed-enhancement imaging for lesion visualization was starting with a delay of 12 minutes after application of 0.1 mmol/kg body weight gadolinium-DTPA, using a breath-hold ECG-gated inversion prepared 3-D FLASH pulse sequence (echo time, 1.1 ms; repetition time, 2.1 ms; flip angle, 8°; slice thickness, 4 to 10 mm; field of view, Ϸ260 mm; matrix, 256*128; inversion time, 220 to 300 ms). Both short-and long-axis slices were acquired for lesion visualization.
Lesion depth was examined separately at the cavotricuspid isthmus just outside the tricuspid valve (atrial side). This region was selected because the landmark of the connective tissue skeleton of the tricuspid valve could be identified easily. Maximum lesion depth and diameter were measured separately from several measurements in each patient (both contrast-enhanced and non-contrast-enhanced).
Data and Statistical Analysis
Lesion size and signal intensity were quantitatively measured directly from the corresponding MRIs using the scanner system console and Philips ViewForum R6.3. The sequence specific SNR was calculated as the signal intensity of the lesion divided by the standard deviation of the background noise. The contrast-to-noise ratio (CNR) was measured as the signal intensity of lesion minus the signal intensity of the adjacent myocardium divided by the standard deviation of the background noise. Magnetic resonance lesion size was determined by the maximum outer margins of the lesion contrast enhancement or signal void. Lesion size was then measured ex vivo at gross examination and compared to the results from the magnetic resonance measurements using linear regression. SPSS 18 (SPSS Inc, Chicago, IL) was used for statistical analysis. The Student t test for paired comparisons was used for comparisons between 2 groups/ imaging techniques; changes over time were evaluated by repeatedmeasures ANOVA followed by Greenhouse-Geisser/Huynh-Feldt correction. For comparisons of the multiple imaging techniques, an ANOVA was first used to compare among all groups (with the probability values shown in the top right corner of the graphs), which in the case of significance was then followed by a paired post hoc comparison using Bonferroni-Holm correction. Unless noted otherwise, results are reported as meanϮstandard deviation (SD).
Results

Catheter Tracking and Ablation in Animals
Guidance of the catheter to the target ablation region (including the right atrium, right ventricular free wall, septum, and coronary sinus) could be achieved in all animals using short pulse sequences for passive in vivo catheter tracking as described. A representative series of images demonstrating passive catheter tracking is given in Figure 1 .
Sensing and pacing testing was successful in all animals. Ablation lesions could be created in 8 of 9 animals, as demonstrated by a decrease in IEGM amplitude. One animal died directly after the beginning of radiofrequency ablation in the right ventricle as the result of ventricular fibrillation.
Assessment of Native T2-Weighted and Delayed-Enhancement T1-Weighted MRI
Intraprocedural magnetic resonance-based lesion visualization was successful in all 8 surviving animals. No catheterinduced artifacts occurred unless the catheter itself caused partial signal void if inside the slide (Figure 1 ).
From the broad spectrum of contrast agent-enhanced and nonenhanced imaging techniques in use, administration of gadolinium-DTPA allowed for particularly precise lesion visualization directly and several minutes after contrast agent delivery. First-pass hypoenhancement clearly indicating myocardial damage with the catheter still in place after ablation is shown exemplary in Figure 1E and 2B and online-only Data Supplement Movie 1. Delayed hyperenhancement is demonstrated in Figure 3G and 3H. We found advantageous lesion visualization starting MRI 12 minutes after contrast agent injection using a breath-hold ECG-gated inversion prepared 3-D FLASH pulse sequence (echo time, 1.1 ms; repetition time, 2.1 ms; flip angle, 8°; slice thickness, 4 to 10 mm; field of view, Ϸ260 mm; matrix, 256*128; inversion time, 220 to 300 ms). Compared with early/first-pass contrast-enhanced MRI, lesion CNR using delayed-enhancement MRI was Ͼ10fold higher (7.89Ϯ1.76 versus 114.66Ϯ32.81, PϽ0.001), mostly because of a much higher imaging robustness (provided comparable image resolution).
Nonenhanced T1-weighted pulse sequences were also used successfully to visualize radiofrequency lesions directly after ablation (Figure 2A ) but provided only relatively poor tissue contrast (CNR, 8.57Ϯ1.88 versus 108.59Ϯ25.38; PϽ0.001, for nonenhancement versus late enhancement in the respective group). Nonenhanced lesion visualization as achieved using a T2-weighted ECG-triggered turbo spin-echo sequence with a black blood pulse is shown exemplarily in Figure 1 and Figure 3 . Additional fat suppression further enhanced CNR (54.99Ϯ19.90 versus 35.90Ϯ12.32, Pϭ 0.003, in sequential imaging) and therefore lesion visibility. The calculated CNR values for lesion visualization using different imaging techniques are summarized in Figure 4A .
Intraprocedural Lesion Mapping in Animals: Spatial and Temporal Development
All lesions could be detected successfully using contrast agent-enhanced T1 contrast as well as using nonenhanced T2 contrast immediately after radiofrequency delivery. Except for the investigations on sequence-specific temporal lesion visualization, which were done using either repetitive T1-or T2-weighted imaging over time, both contrast-enhanced and nonenhanced images were achieved in the first hour after ablation, starting with nonenhanced imaging.
Experiments on temporal development of lesion size showed that lesion size as determined by MRI was not significantly different immediately after ablation and during subacute follow-up but remained almost the same after the initial measurements ( Figure 3 ). Temporal development of lesion size was determined using native T2-weighted imaging sequences. The average lesion size was 31.3Ϯ1.6 mm 2 after 3 minutes, 33.0Ϯ1.8 mm 2 after 5 minutes, 32.3Ϯ2.0 mm 2 after 10 minutes, 33.2Ϯ1.7 mm 2 after 30 minutes, 31.3Ϯ 1.5 mm 2 after 60 minutes, and 33.3Ϯ1.6 mm 2 after 360 minutes and therefore did not differ significantly over time (Pϭ0.277, Figure 4B ).
Compared with the corresponding pathological specimen (32.4Ϯ7.3 mm 2 ), comparable lesion sizes (maximum lengthϫ maximum depth) were observed in the delayed contrastenhanced T1-weighted images (nϭ8, 32.8Ϯ5.3 mm 2 , Pϭ0.75), with a tendency for a slightly larger lesion size in the native T2-weighted images (nϭ8, 35.9Ϯ6.2 mm 2 , Pϭ0.006). Linear regression analyses of the lesion diameter measured by MRI showed good agreement of both imaging techniques compared with pathology (r 2 ϭ0.709, Pϭ0.017 for T2 and r 2 ϭ0.799, Pϭ0.007, for T1 LE [late enhancement], Figure 4 ). A and B) , the possibility to adjust signal intensity by changing sequence parameters is important to allow adequate lesion imaging without artifacts later during an interventional electrophysiological procedure with the catheter in place. C, Guidance of the catheter to the target, with the catheter body going from the left jugular vein and the upper vena cava through the right atrium and the lower vena cava back to the coronary sinus. D, After reaching final catheter position, radiofrequency ablation was performed, followed by several pulse sequences aiming at visualization of ablation lesions. Two techniques applicable shortly after ablation are shown. E, Myocardial hyperenhancement (edema, white arrow) using black blood T2 contrast after 3 minutes. F, Myocardial hypoenhancement (perfusion deficit, white arrow) using T1 contrast directly after gadolinium-DTPA injection. Note that slice selection in E and F is slightly different compared with C and D to focus on left ventricular myocardium at the heart base while excluding the catheter signal void. LV indicates left ventricle.
Temporal lesion visibility was also investigated using T1-weighted delayed enhancement protocols. In both atrial and ventricular tissue, not only late-enhancement signal intensity but also visible lesion size decreased over time after contrast agent injection ( Figure 3G and 3H) . Specifically, 2 hours after injection, mean lesion signal intensity decreased from 1073Ϯ93 to 662Ϯ114 (PϽ0.001), but only 775Ϯ52 for the lesion center (Pϭ0.02 for SI difference), meaning that small central lesion parts could still be visualized without further contrast agent injection but not the lesion in total ( Figure 3H ).
Lesion Imaging in Patients
A total of 24 patients were examined. Patient characteristics are given in the Table. Preprocedural MRI showed no morphological specificities at the cavotricuspid isthmus in any patient before ablation therapy using nonenhanced imaging techniques. All patients had atrial flutter and underwent standard radiofrequency ablation therapy to achieve complete bidirectional conduction block of the cavotricuspid isthmus. Ablation details are given in online-only Data Supplement Table 1 . In all patients, cardiac MRI could then successfully be performed within 24 hours after ablation of the cavotricuspid isthmus.
Thermal lesions after interventional electrophysiology could be visualized in all patients after ablation with a T1-weighted delayed-enhancement technique (starting MRI 12 minutes after application of 0.1 mmol/kg gadolinium-DTPA) as well as using nonenhanced T2-weighted imaging performed directly before contrast agent delivery. Hyperenhancement in the right atrium at the cavotricuspid isthmus was seen in all these patients after radiofrequency ablation with both contrast-enhanced and nonenhanced MRI. Examples of contrast-enhanced lesion visualization after atrial flutter ablation are given in Figure 5 . Nonenhanced lesion visualization after atrial flutter ablation is demonstrated in Figure 6 and Figure 7 . Mean SNR and CNR for all patients was higher for T1 LE imaging compared with T2 imaging (PϽ0.001, Figure 8 ). T2 CNR values showed higher relative variations compared with T1 LE between the patients, as apparent in the higher relative standard deviation of T2 CNR. Perfusion imaging for lesion visualization was not performed in patients because of lower CNR/resolution and higher susceptibility to image artifacts.
Lesions were found not only at the (atrial) isthmus itself but additionally covering parts of the right ventricular base adjacent to the cavotricuspid isthmus in most cases ( Figures  5C, 6, and 7) . These ventricular lesions showed a tendency for lower SNR and CNR values compared with the respective atrial ablation (CNR, 94.6Ϯ35.2 versus 111.1Ϯ32.6, Pϭ0.42 for T1 LE, and 48.0Ϯ29.0 versus 68.0Ϯ37.3, Pϭ0.012 for T2), which had not been seen in the animal experiments ( Figure 8 ). Lesion depth acquired by both imaging techniques showed good agreement with a trend for higher values using native T2-weighted imaging (r 2 ϭ0.790, PϽ0.001 for linear regression analysis, Figure 8C ), and excellent agreement for lesion diameter (r 2 ϭ0.992, PϽ0.001, Figure 8D ). Serial image acquisitions over time in single patients showed an excellent reproducibility for native T2-weighted imaging with only minimum changes in lesion CNR ( Figure 8E ). Serial image acquisitions using T1 LE adopting only the inversion over time showed a small additional increase in CNR from 15 to 25 and 35 minutes (Pϭ0.003, Figure 8E ).
Clinical Investigations: Patient Outcome
In 2 patients, atrial flutter could not be terminated successfully by radiofrequency ablation during the first intervention. The first patient underwent DC cardioversion to establish sinus rhythm; this case is demonstrated in Figure 7 . Failure of successful ablation was confirmed through intracardiac ECG tracings, showing the absence of split potentials in the MAP (mapping) catheter when pacing from the coronary sinus as sign of incomplete isthmus block. Postablation imaging with both contrast-enhanced and nonenhanced MRI revealed an incomplete ablation line with interruption in the otherwise clearly visible hyperintense ablation line ( Figure 7A and 7B) . After recurrence of a second episode of atrial flutter, the patient again received radiofrequency ablation using irrigated radiofrequency ablation technique. Successful bidirectional isthmus block was confirmed during the electrophysiological study. Subsequently, a continuous ablation line could also be demonstrated in the MRI (Figure 7C ) after the second intervention. Calculations of this lesion's signal intensity showed a further signal increase and lower signal variation at the atrial isthmus which had been targeted by reablation (1926Ϯ238 after 2nd versus 1253Ϯ339 after 1st ablation, PϽ0.001). Contrarily, signal intensity in the ventricular lesion part that had not been targeted during the second ablation showed a signal decrease (1073Ϯ223 versus 1213Ϯ142, PϽ0.001) ( Figure 8F) .
In a second patient, there was also no complete isthmus blockade as indicated by missing split potentials and MRI. This patient refused further treatment using radiofrequency or cryoablation. All other patients were free of atrial flutter in the postablation 3-month interval (online-only Data Supplement Table 2 ). Thus, there was a good correlation between bidirectional isthmus block during the electrophysiological study with the findings from the magnetic resonance study.
Discussion
MRI for Guidance of Electrophysiological Interventions
A major obstacle in ablation procedures is the inability to gain information on the extent of the thermal lesion after delivering radiofrequency energy, although this is crucial to determine the success or failure of the procedure. Especially in case of long linear lesions, the possibility for direct lesion visualization would be helpful to find remaining gaps. We now extended the potential of magnetic resonance-guided electrophysiology, showing that ablation lesions can be directly visualized after ablation in good agreement with anatomic findings, using an animal model of targeted ablation with the catheter still in place. Various regions in right atrium, ventricle, and coronary sinus were successfully targeted and ablated in living animals using steerable catheters with real-time magnetic resonance fluoroscopy pulse sequences. The high-resolution images of endocardial anatomy considerably improved targeting and accurate lesion placement (Figures 1 through 3) , whereas standard x-ray fluoroscopy, in contrast, generally delivers poor tissue contrast.
Animal Experiments: Procedural Safety and Adverse Events
There is a substantial danger for technical equipment to interfere with the electromagnetic fields inherent in MRI technology. 14 Regarding magnetic resonance-guided interventional electrophysiology, there are particular safety concerns regarding unintended catheter heating caused by radiofrequency coupling (which can be difficult to foresee 15, 16 ), and electrophysiological device malfunction, for example, through electric interference during imaging. Additionally, magnetic resonance-compatible equipment or specific imaging sequences are warranted to avoid imaging artifacts. Recently, substantial improvements of hardware and software enabled diagnostic 10 and even interventional electrophysiology in the MRI environment in animals for the first time. 12 Even though to date there still is no electrophysiology setup officially approved for magnetic resonance-guided electrophysiological interventions in patients, there are several groups actively working to overcome the remaining issues.
The present animal experiments provide evidence for applicability and safety of magnetic resonance-guided electrophysiological interventions in a clinical setup, including intraprocedural magnetic resonance lesion visualization. One animal of 9 died as the result of ventricular fibrillation. However, this event was directly related to radiofrequency ablation and can therefore not be attributed to the use of MRI. The species-specific high susceptibility of pigs to ventricular tachycardia is well known. No further adverse events occurred in the present study.
MRI for Electrophysiological Lesion Visualization
The current study showed that MRI can visualize acute and subacute ablation lesions not only in an experimental setup but also in patients after cavotricuspid isthmus ablation. Delayed enhancement imaging has been shown to be suitable to detect subacute and chronic lesions with high resolution and good precision. 1, 2, [5] [6] [7] [8] Our findings are in good agreement with these reports, now adding evidence that even acute lesions can be successfully visualized with contrast-enhanced MRI both in an experimental and clinical setup. In general, contrast-enhanced MRI is a valuable tool for lesion visualization, being a standard procedure offering relatively easy visualization of ablation lesions with good detectability even of small atrial lesions in patients. 7, 8 On the other hand, this approach is more suitable for postprocedural imaging and would be problematic in a real-time interventional approach because of limitations in the amount of contrast agent delivery and imaging problems if multiple contrast agent boluses are needed. Therefore, nonenhanced imaging is desirable in an interventional approach.
Contrast-Enhanced Versus Nonenhanced Lesion Visualization
It has been recently shown in an animal model that exposure of epicardial ablation lesions is even possible with nonenhanced MRI, for example, using T2-weighted pulse sequences, which could be advantageous not only for fast lesion detection but also for lesion characterization. 3 The potential of T2-weighted MRI to detect myocardial injury is particularly well investigated in patients with myocarditis [17] [18] [19] [20] and after myocardial infarction. 20 -24 In our experiments, we were able to detect small lesions of only several millimeters in diameter with good precision 2 minutes after ablation using T2-weighted pulse sequences with a black blood technique and fat suppression. Moreover, in a patient with incomplete isthmus block after ablation as determined by IEGM, we were able to visualize an incomplete ablation lesion line with a non-contrast agentenhanced imaging technique. This demonstrates the potential of nonenhanced MRI for lesion visualization, even though further efforts are warranted to increase imaging technique robustness, particularly at the desired high spatial resolutions.
In our experience, delayed enhancement imaging using contrast agent generally was more suitable for postprocedural lesion mapping, particularly because of their robustness, whereas nonenhanced T2 imaging techniques are highly advantageous for intraprocedural mapping because they do not rely on time consuming contrast agent washout and can be repeated as often as needed during interventions. Meanwhile, combining several Figure 6 . Nonenhanced lesion visualization in patients after atrial flutter ablation. Demonstration of nonenhanced isthmus ablation lesion visualization in a female patient in the right ventricular 2-chamber view. A, Anatomic overview before isthmus ablation. This isthmus is marked by an arrow. B, Preprocedural T2-weighted black blood gradient echo sequence. Because of the low signal intensity, the isthmus is hardly visible. C, Same pulse sequence 45 minutes after isthmus ablation. The isthmus is well visible, but lesion contrast to surrounding myocardium and discrimination to connective (fatty) tissue is limited. D and E, By using additional SPIR (spectral presaturation inversion recovery) fat suppression, lesion contrast is greatly increased. F, Maximum intensity projection showing the ablation lesion at the cavotricuspid isthmus. The small cavity inside the lesion is the coronary sinus.
MRI techniques (nonenhanced T2, early and late contrastenhanced T1, perfusion) could be suitable not only to visualize ablation lesions but also to allow for further ablation characterization. During in vivo endocardial ablation the intensity of tissue-catheter contact changes; therefore, usually lesion sites after endocardial ablation are heterogeneous because the targeted tissue is damaged to a different extent. Areas of necrosis, hemorrhage, and edema are in close proximity or even merged. This might result in complex wash-in and wash-out kinetics of contrast agents, which-in combination with changing contrast behavior in nonenhanced imaging-potentially allow for differentiation of temporal from permanent myocardial damage. In our setup, nonenhanced T2 and first-pass T1 contrast delivering gadolinium-DTPA visually revealed slightly different lesion . C-1, Postprocedural nonenhanced T2-weighted gradient echo sequence with black blood pulse and fat suppression in the same patient after the second ablation procedure using a cooled tip ablation technique. C-2, Maximum intensity projection after the second ablation process. Complete conduction block is demonstrated in the IEGM (C-2). The small cavity in the lesion middle is the coronary sinus (C-3). Because the patient had already received 3 doses of contrast agent in different magnetic resonance investigations over a very short period of time before, we did not perform late-enhancement imaging after this second ablation procedure.
patterns (Figure 1) . One study has reported on differences in peripheral "delayed enhancement" and central "very delayed" enhancement of ablation lesions, possibly caused by different degrees in myocardial damage. 2 Similarly, in our study, contrast agent washout appeared to be slower in parts of larger lesions, possibly because of the development of central necrosis ( Figure  3) . The ability to directly visualize temporal myocardial damage would be a major advance in interventional electrophysiology.
Theoretical assumptions suppose changes in lesion size over time as inflammation and healing appear, and this has just recently been reported regarding long-term follow-up of ablation lesions, 8 and also in the short-term follow-up. 3 In contrast, investigations in our setup showed that the visualized lesion size was not significantly changing over time immediately after ablation and during subacute follow-up but remained constant during the first hours after the initial measurements (Figure 3 and Figure 4 ).
Limitations and Perspective
Only endocardial lesions were investigated in the current setup and therefore the results should not be extended to epicardial lesions, which may show different behavior especially over time because of differences in tissue and perfusion The inversion time was adopted over time. Native T2 imaging was performed before contrast agent delivery. F, Repetitive T2-weighted lesion imaging in a patient before and after 2 ablation procedures at the cavotricuspid isthmus, signal intensity ϮSD is shown for the atrial and ventricular ablation site and remote ventricular and atrial myocardium separately. Incomplete conduction block after the first ablation therapy required a second ablation, after which a further increase in atrial but not ventricular signal intensity was found.
characteristics. Furthermore, only lesions from standard radiofrequency ablation were investigated. Based on the results, MRI has proven to be an expedient tool for immediate visualization of therapeutic lesions after radiofrequency ablation. Particularly, nonenhanced MRI has the potential to improve future complex electrophysiological interventions because it is repeatable multiple times during interventions and lesions are visible only minutes after radiofrequency delivery. Further advances in imaging techniques have to be established to use MRI-guided electrophysiological interventions to full capacity. In particular, there is a desire not only for exact visualization but also characterization of ablation lesions, that is, a clear discrimination between permanent ablation lesions and regions with transient cardiac edema. Although MRI guidance of electrophysiological interventions is applicable to all cardiac arrhythmias, it may be particularly well suited for more complex arrhythmias that require the accurate placement of multiple, linearly arranged lesions, with the benefit to facilitate real-time detection (and possibly prevention) of complications. Combining several imaging techniques (eg, adding MRI thermometry) would enable the electrophysiologist to assess additional information that could improve electrophysiological procedures, increasing the success rate while decreasing procedural duration.
Conclusion
Real-time MRI for guidance of interventional electrophysiology is an area of great potential that is expected to further enhance the abilities in interventional approaches of complex arrhythmias. As a further component in solving the remaining technical challenges, the current study provides evidence that intraprocedural MRI is feasible for visualization of acute radiofrequency ablation lesions in an experimental model and subacute lesions in patients directly after ablation therapy of typical atrial flutter. Not only contrast agent-enhanced but particularly nonenhanced imaging techniques are suitable for real-time ablation lesion visualization, allowing for sequential intraprocedural lesion imaging, which could be crucial for the decision on further ablation strategies during interventional electrophysiology.
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